THE ADVENT of the sulfonamides and antibiotics provided physicians with means of combating most of the infections met in their daily practice. The spectrums of effectiveness of these drugs cover most of the common organisms, and the diseases these organisms produce usually wilt with the action of these drugs. However, there still remains, in significant numbers, a group of chronic infections—a residue of the presulfonamide period or the result of recent infection—with a fast or resistant organism. In this group is chronic purulent middle ear disease. Patients usually have a profuse, foul, mucopurulent discharge due to infection from a mixture of organisms. These infections have persisted despite all medical treatment and, frequently, rigorous repeated surgical treatment. One reason for this situation is that many of the organisms are in the family of Pseudomonas aeruginosa and Proteus vulgaris, which up to now have defied treatment. A second reason is that these
OCHS IL. USE OF VINEGAR AS AN ANTIBIOTIC IN THE TREATMENT OF CHRONIC MIDDLE EAR DISEASE. AMA Arch Otolaryngol. 1950;52(6):935–941. doi:10.1001/archotol.1950.00700030962010
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: